Skip to main content
. Author manuscript; available in PMC: 2024 Jan 25.
Published in final edited form as: Expert Rev Ophthalmol. 2020 May 14;15(3):145–157. doi: 10.1080/17469899.2020.1762488

Table 2.

Comparisons of Anti-inflammatory Potency and Ocular Penetration of Topical Ocular Glucocorticoids

Glucocorticoid Relative Anti-inflammatory Activity Dose Peak Aqueous Humor Concentration (ng/mL) Time to Peak (minutes) IOP Rise (mmHg)
Cortisol 1 0.5% 3.2
Prednisolone 4 1% 7650 30 10.0
Prednisolone Acetate 4 1% 670–1130 45–120
Prednisolone Phosphate 4 1% 26 90–240
Fluorometholone 40 0.1% 5.1 30–60 6.1
Dexamethasone 25 0.1% 31 90–120 22.0
Dexamethasone Phosphate 25 0.1% 31 55
Medrysone 4 1% 1.0
Loteprednol etabonate 25 0.5% * *
Rimexolone 25 1% ~6
Difluprednate emulsion 60 0.05% 30 60
*

Rapidly metabolized and inactivated in cornea (Druzgala P et al. PMID 1959381)[124]

Data from: Murdick PW, Keates RH, Donovan EF et al. (PMID: 5928150)[125]

Awan MA, Agarwal PK, Watson DG et al (PMID: 19293163)[126]

Razeghinejad MR, Katz L (PMID: 21757964)[127]

Yamaguchi M, Yasueda S et al (PMID: 16023810)[128]